ArticleFrontiers in immunology2022

SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients - a comparative long term post-infection study.

Jessica Brehm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.